| scholarly article | Q13442814 |
| P2093 | author name string | Hyun Jung Kim | |
| Han Jo Kim | |||
| Sang-Cheol Lee | |||
| Jong-Ho Won | |||
| Se Hyung Kim | |||
| Seong-Kyu Park | |||
| Chan Kyu Kim | |||
| Jun Young Eun | |||
| Dae Sik Hong | |||
| Hee Sook Park | |||
| Jina Yun | |||
| Kyoung Ha Kim | |||
| Kyu Taek Lee | |||
| Nam Su Lee | |||
| Sang Byung Bae | |||
| Young Woo Jeon | |||
| P2860 | cites work | Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 |
| Oxaliplatin-induced damage of cellular DNA | Q60641674 | ||
| Phase I study of oxaliplatin in patients with advanced cancer | Q68692409 | ||
| Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines | Q72018747 | ||
| Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the | Q74000577 | ||
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines | Q31122902 | ||
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | Q33313072 | ||
| Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients | Q33345474 | ||
| Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer | Q33346628 | ||
| Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer | Q33359580 | ||
| Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. | Q33361500 | ||
| Pharmacokinetics and safety profile of oxaliplatin | Q34066653 | ||
| Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. | Q36615060 | ||
| Chemotherapy for metastatic gastric cancer: past, present, and future | Q37155553 | ||
| Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer | Q37336375 | ||
| Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line. | Q40579698 | ||
| Role of carrier ligand in platinum resistance of human carcinoma cell lines | Q41573341 | ||
| Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial | Q42285544 | ||
| Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer | Q43993881 | ||
| Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie | Q46694609 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| oxaliplatin | Q422327 | ||
| P304 | page(s) | 154-159 | |
| P577 | publication date | 2011-09-30 | |
| P1433 | published in | Cancer Research and Treatment | Q18411021 |
| P1476 | title | Efficacy and safety of oxaliplatin, 5-Fluorouracil, and folinic Acid combination chemotherapy as first-line treatment in metastatic or recurrent gastric cancer | |
| P478 | volume | 43 |
| Q39136321 | Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells |
| Q34335408 | Function of chloride intracellular channel 1 in gastric cancer cells |
| Q36347106 | Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer |
| Q39558472 | The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents. |
Search more.